These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36297318)

  • 1. Chitosan/Cyclodextrin Nanospheres for Potential Nose-to-Brain Targeting of Idebenone.
    De Gaetano F; d'Avanzo N; Mancuso A; De Gaetano A; Paladini G; Caridi F; Venuti V; Paolino D; Ventura CA
    Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical Characterization and Antioxidant Activity Evaluation of Idebenone/Hydroxypropyl-
    Venuti V; Crupi V; Fazio B; Majolino D; Acri G; Testagrossa B; Stancanelli R; De Gaetano F; Gagliardi A; Paolino D; Floresta G; Pistarà V; Rescifina A; Ventura CA
    Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31557949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Chitosan/Cyclodextrin Nanospheres for Levofloxacin Ocular Delivery.
    De Gaetano F; Marino A; Marchetta A; Bongiorno C; Zagami R; Cristiano MC; Paolino D; Pistarà V; Ventura CA
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
    Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T
    Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphiphilic Cyclodextrin Nanoparticles as Delivery System for Idebenone: A Preformulation Study.
    De Gaetano F; Scala A; Celesti C; Lambertsen Larsen K; Genovese F; Bongiorno C; Leggio L; Iraci N; Iraci N; Mazzaglia A; Ventura CA
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study.
    Elmoghayer ME; Saleh NM; Abu Hashim II
    Drug Deliv Transl Res; 2024 Apr; 14(4):895-917. PubMed ID: 37843733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.
    Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F
    Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
    Zhang P; Liu X; Hu W; Bai Y; Zhang L
    Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.
    Liu S; Ho PC
    J Pharm Pharmacol; 2017 Nov; 69(11):1495-1501. PubMed ID: 28809432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.
    Yurtdaş-Kırımlıoğlu G
    Drug Dev Ind Pharm; 2021 Aug; 47(8):1261-1278. PubMed ID: 34606394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release.
    Tang P; Yang H; Tang B; Wu D; Du Q; Xu K; Li H
    Carbohydr Polym; 2017 Jan; 156():215-222. PubMed ID: 27842816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.
    Trapani A; Lopedota A; Franco M; Cioffi N; Ieva E; Garcia-Fuentes M; Alonso MJ
    Eur J Pharm Biopharm; 2010 May; 75(1):26-32. PubMed ID: 20102738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity.
    Tang P; Sun Q; Zhao L; Pu H; Yang H; Zhang S; Gan R; Gan N; Li H
    Carbohydr Polym; 2018 Oct; 198():418-425. PubMed ID: 30093018
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhang L; Yang S; Wong LR; Xie H; Ho PC
    Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomly methylated β-cyclodextrin improves water - solubility, cellular protection and mucosa permeability of idebenone.
    De Gaetano F; Mannino D; Celesti C; Bulzomí M; Iraci N; Vincenzo Giofrè S; Esposito E; Paterniti I; Anna Ventura C
    Int J Pharm; 2024 Nov; 665():124718. PubMed ID: 39288841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics.
    Fülöp Z; Saokham P; Loftsson T
    Int J Pharm; 2014 Sep; 472(1-2):282-7. PubMed ID: 24971695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery.
    Ricci F; Racaniello GF; Lopedota A; Laquintana V; Arduino I; Lopalco A; Cutrignelli A; Franco M; Sigurdsson HH; Denora N
    Int J Pharm; 2022 Jun; 622():121905. PubMed ID: 35697201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-in-cyclodextrin-in-polymeric nanoparticles: A promising strategy for rifampicin administration.
    Abruzzo A; Croatti V; Zuccheri G; Pasquale Nicoletta F; Sallustio V; Corazza E; Vitali B; Cerchiara T; Luppi B; Bigucci F
    Eur J Pharm Biopharm; 2022 Nov; 180():190-200. PubMed ID: 36210035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
    Shinde UA; Joshi PN; Jain DD; Singh K
    Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Ibrutinib Delivery: A Potential Nanoformulation of Novel Kinase Inhibitor.
    Zhao L; Tang B; Tang P; Sun Q; Suo Z; Zhang M; Gan N; Yang H; Li H
    J Pharm Sci; 2020 Feb; 109(2):1136-1144. PubMed ID: 31606544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.